Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: the Pan-Canadian Oncology Drug Review.

Literature DB >> 23559876

Informing Canada's cancer drug funding decisions with scientific evidence and patient perspectives: the Pan-Canadian Oncology Drug Review.

J S Hoch¹, M Sabharwal.

Abstract

Entities: Disease Species

Year: 2013 PMID： 23559876 PMCID： PMC3615855 DOI： 10.3747/co.20.1315

Source DB: PubMed Journal: Curr Oncol ISSN： 1198-0052 Impact factor: 3.677

× No keyword cloud information.

3 in total

1. Limits on Medicare's ability to control rising spending on cancer drugs.

Authors: Peter B Bach
Journal: N Engl J Med Date: 2009-01-27 Impact factor: 91.245

2. How much is life worth: cetuximab, non-small cell lung cancer, and the $440 billion question.

Authors: Tito Fojo; Christine Grady
Journal: J Natl Cancer Inst Date: 2009-06-29 Impact factor: 13.506

3. American Society of Clinical Oncology guidance statement: the cost of cancer care.

Authors: Neal J Meropol; Deborah Schrag; Thomas J Smith; Therese M Mulvey; Robert M Langdon; Diane Blum; Peter A Ubel; Lowell E Schnipper
Journal: J Clin Oncol Date: 2009-07-06 Impact factor: 44.544

3 in total

19 in total

1. Understanding the reasons for provincial discordance in cancer drug funding-a survey of policymakers.

Authors: A Srikanthan; N Penner; K K W Chan; M Sabharwal; A Grill
Journal: Curr Oncol Date: 2018-08-14 Impact factor: 3.677

2. A Time-Trend Economic Analysis of Cancer Drug Trials.

Authors: Sonya Cressman; George P Browman; Jeffrey S Hoch; Laurel Kovacic; Stuart J Peacock
Journal: Oncologist Date: 2015-06-01

3. Meaningful patient representation informing Canada's cancer drug funding decisions: views of patient representatives on the Pan-Canadian Oncology Drug Review.

Authors: J S Hoch; M B Brown; C McMahon; J Nanson; L Rozmovits
Journal: Curr Oncol Date: 2014-10 Impact factor: 3.677

4. The politicization of oncology drug funding reviews in Canada.

Authors: C Skedgel; T Younis
Journal: Curr Oncol Date: 2016-06-09 Impact factor: 3.677

5. Provincial elections and timing of cancer drug funding.

Authors: A Srikanthan; S S Gill; K K W Chan
Journal: Curr Oncol Date: 2016-06-09 Impact factor: 3.677

6. Impact of the pan-Canadian Oncology Drug Review on provincial concordance with respect to cancer drug funding decisions and time to funding.

Authors: A Srikanthan; H Mai; N Penner; E Amir; A Laupacis; M Sabharwal; K K W Chan
Journal: Curr Oncol Date: 2017-10-25 Impact factor: 3.677